Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$110.37
-0.6%
$118.68
$100.85
▼
$212.00
$3.64B1.45519,300 shs350,058 shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$391.95
-2.3%
$380.62
$328.57
▼
$603.88
$138.47B1.462.33 million shs1.83 million shs
UiPath, Inc. stock logo
PATH
UiPath
$13.11
-1.5%
$14.69
$9.20
▼
$19.84
$6.84B1.0151.20 million shs19.68 million shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.00%-0.01%-10.58%-12.74%-34.09%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%-3.27%+5.98%-8.00%-10.52%
UiPath, Inc. stock logo
PATH
UiPath
0.00%+5.14%-27.51%+12.32%+0.68%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$110.37
-0.6%
$118.68
$100.85
▼
$212.00
$3.64B1.45519,300 shs350,058 shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$391.95
-2.3%
$380.62
$328.57
▼
$603.88
$138.47B1.462.33 million shs1.83 million shs
UiPath, Inc. stock logo
PATH
UiPath
$13.11
-1.5%
$14.69
$9.20
▼
$19.84
$6.84B1.0151.20 million shs19.68 million shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.00%-0.01%-10.58%-12.74%-34.09%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%-3.27%+5.98%-8.00%-10.52%
UiPath, Inc. stock logo
PATH
UiPath
0.00%+5.14%-27.51%+12.32%+0.68%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.94
Moderate Buy$179.9363.02% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.68
Moderate Buy$508.6829.78% Upside
UiPath, Inc. stock logo
PATH
UiPath
2.10
Hold$15.6919.62% Upside

Current Analyst Ratings Breakdown

Latest ISRG, IRTC, and PATH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/28/2026
UiPath, Inc. stock logo
PATH
UiPath
Reiterated RatingNeutral ➝ Underperform$10.00
9/28/2026
UiPath, Inc. stock logo
PATH
UiPath
DowngradeNeutral ➝ Underperform$10.00
9/25/2026
UiPath, Inc. stock logo
PATH
UiPath
Lower Price TargetNeutral$19.00 ➝ $14.00
9/24/2026
UiPath, Inc. stock logo
PATH
UiPath
Reiterated RatingSector Weight
9/24/2026
UiPath, Inc. stock logo
PATH
UiPath
Set Price Target$15.00
9/24/2026
UiPath, Inc. stock logo
PATH
UiPath
Lower Price TargetHold$17.00 ➝ $14.00
9/24/2026
UiPath, Inc. stock logo
PATH
UiPath
Lower Price TargetMarket Perform$18.00 ➝ $15.00
9/23/2026
UiPath, Inc. stock logo
PATH
UiPath
Reiterated RatingOutperform
9/23/2026
UiPath, Inc. stock logo
PATH
UiPath
Reiterated RatingBuy
9/23/2026
UiPath, Inc. stock logo
PATH
UiPath
Lower Price TargetHold$17.00 ➝ $14.00
9/14/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Reiterated RatingSell (D-)
(Data available from 10/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$747.14M4.87N/AN/A$4.74 per share23.28
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$10.06B13.76$9.28 per share42.25$50.52 per share7.76
UiPath, Inc. stock logo
PATH
UiPath
$1.61B4.24$0.39 per share33.60$3.74 per share3.51
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$44.55M-$0.43N/A76.12N/A-1.69%10.11%1.53%10/29/2026 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.7344.9039.122.9628.45%16.91%14.83%10/20/2026 (Estimated)
UiPath, Inc. stock logo
PATH
UiPath
$282.33M$0.6719.5723.011.2321.03%9.70%6.42%12/2/2026 (Estimated)

Latest ISRG, IRTC, and PATH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/29/2026Q3 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$0.02N/AN/AN/A$222.45 millionN/A
10/20/2026Q3 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.64N/AN/AN/A$2.91 billionN/A
9/3/2026Q2 2027
UiPath, Inc. stock logo
PATH
UiPath
$0.1485$0.15+$0.0015$0.07$397.77 million$410.26 million
8/6/2026Q2 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.04$0.58+$0.62-$0.01$219.30 million$224.17 million
7/16/2026Q2 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.48$2.80+$0.32$2.29$2.83 billion$2.89 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
UiPath, Inc. stock logo
PATH
UiPath
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
3.50
3.86
3.74
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.96
3.91
UiPath, Inc. stock logo
PATH
UiPath
N/A
2.39
2.39

Institutional Ownership

CompanyInstitutional Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
UiPath, Inc. stock logo
PATH
UiPath
62.50%

Insider Ownership

CompanyInsider Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.98%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
UiPath, Inc. stock logo
PATH
UiPath
22.44%
CompanyEmployeesShares OutstandingFree FloatOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,40032.96 million32.64 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021353.28 million351.16 millionOptionable
UiPath, Inc. stock logo
PATH
UiPath
3,981521.16 million404.21 millionOptionable

Recent News About These Companies

UiPath: Large Account Growth Is Compelling
UiPath: Worth Picking Up At This Price (Rating Upgrade)
Uipath, Inc. and Snowflake Inc. Announce Two-Way Integration
UiPath, Snowflake Expand Collaboration

New MarketBeat Followers Over Time

Media Sentiment Over Time

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$110.37 -0.68 (-0.61%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$110.40 +0.03 (+0.03%)
As of 10/2/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$391.95 -9.29 (-2.32%)
Closing price 10/2/2026 04:00 PM Eastern
Extended Trading
$391.30 -0.65 (-0.17%)
As of 10/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

UiPath stock logo

UiPath NYSE:PATH

$13.11 -0.21 (-1.55%)
Closing price 10/2/2026 03:59 PM Eastern
Extended Trading
$13.09 -0.02 (-0.15%)
As of 10/2/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York.